{
  "DOI": "10.1186/s40246-018-0183-1",
  "ISSN": [
    "1479-7364"
  ],
  "URL": "http://dx.doi.org/10.1186/s40246-018-0183-1",
  "alternative-id": [
    "183"
  ],
  "article-number": "51",
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "31 August 2018"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "8 November 2018"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "20 November 2018"
    },
    {
      "group": {
        "label": "Ethics approval and consent to participate",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1,
      "value": "Not applicable."
    },
    {
      "group": {
        "label": "Consent for publication",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "Not applicable."
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "The authors declare that they have no competing interests."
    },
    {
      "group": {
        "label": "Publisher’s Note",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 4,
      "value": "Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Langerud",
      "given": "Jonas",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Jarhelle",
      "given": "Elisabeth",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Van Ghelue",
      "given": "Marijke",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Ariansen",
      "given": "Sarah Louise",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Iversen",
      "given": "Nina",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genomics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2018,
        11,
        20
      ]
    ],
    "date-time": "2018-11-20T13:29:09Z",
    "timestamp": 1542720549000
  },
  "deposited": {
    "date-parts": [
      [
        2019,
        11,
        20
      ]
    ],
    "date-time": "2019-11-20T00:05:58Z",
    "timestamp": 1574208358000
  },
  "indexed": {
    "date-parts": [
      [
        2023,
        8,
        10
      ]
    ],
    "date-time": "2023-08-10T15:54:32Z",
    "timestamp": 1691682872365
  },
  "is-referenced-by-count": 3,
  "issn-type": [
    {
      "type": "electronic",
      "value": "1479-7364"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2018,
        11,
        20
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-print": {
      "date-parts": [
        [
          2018,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://creativecommons.org/licenses/by/4.0/",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2018,
            11,
            20
          ]
        ],
        "date-time": "2018-11-20T00:00:00Z",
        "timestamp": 1542672000000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1186/s40246-018-0183-1.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1186/s40246-018-0183-1/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1186/s40246-018-0183-1.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "prefix": "10.1186",
  "published": {
    "date-parts": [
      [
        2018,
        11,
        20
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2018,
        11,
        20
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2018,
        12
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "key": "183_CR1",
      "unstructured": "IARC. GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012 \n                    http://globocan.iarc.fr/Pages/fact_sheets_population.aspx?country=900\n                    \n                   Available from: \n                    http://globocan.iarc.fr/Pages/fact_sheets_population.aspx?country=900\n                    \n                  ."
    },
    {
      "DOI": "10.1016/j.critrevonc.2016.10.008",
      "author": "C van Marcke",
      "doi-asserted-by": "publisher",
      "first-page": "33",
      "journal-title": "Crit Rev Oncol Hematol",
      "key": "183_CR2",
      "unstructured": "van Marcke C, De Leener A, Berliere M, Vikkula M, Duhoux FP. Routine use of gene panel testing in hereditary breast cancer should be performed with caution. Crit Rev Oncol Hematol. 2016;108:33–9.",
      "volume": "108",
      "year": "2016"
    },
    {
      "DOI": "10.1038/nrc3181",
      "author": "R Roy",
      "doi-asserted-by": "publisher",
      "first-page": "68",
      "issue": "1",
      "journal-title": "Nat Rev Cancer",
      "key": "183_CR3",
      "unstructured": "Roy R, Chun J, Powell SN. BRCA1 and BRCA2: different roles in a common pathway of genome protection. Nat Rev Cancer. 2011;12(1):68–78.",
      "volume": "12",
      "year": "2011"
    },
    {
      "DOI": "10.1038/nrc.2016.72",
      "author": "FC Nielsen",
      "doi-asserted-by": "publisher",
      "first-page": "599",
      "issue": "9",
      "journal-title": "Nat Rev Cancer",
      "key": "183_CR4",
      "unstructured": "Nielsen FC, van Overeem HT, Sorensen CS. Hereditary breast and ovarian cancer: new genes in confined pathways. Nat Rev Cancer. 2016;16(9):599–612.",
      "volume": "16",
      "year": "2016"
    },
    {
      "DOI": "10.1530/ERC-16-0221",
      "author": "Y Katsuki",
      "doi-asserted-by": "publisher",
      "first-page": "T19",
      "issue": "10",
      "journal-title": "Endocr Relat Cancer",
      "key": "183_CR5",
      "unstructured": "Katsuki Y, Takata M. Defects in homologous recombination repair behind the human diseases: FA and HBOC. Endocr Relat Cancer. 2016;23(10):T19–37.",
      "volume": "23",
      "year": "2016"
    },
    {
      "DOI": "10.1002/humu.22150",
      "author": "GA Millot",
      "doi-asserted-by": "publisher",
      "first-page": "1526",
      "issue": "11",
      "journal-title": "Hum Mutat",
      "key": "183_CR6",
      "unstructured": "Millot GA, Carvalho MA, Caputo SM, Vreeswijk MP, Brown MA, Webb M, et al. A guide for functional analysis of BRCA1 variants of uncertain significance. Hum Mutat. 2012;33(11):1526–37.",
      "volume": "33",
      "year": "2012"
    },
    {
      "DOI": "10.2478/s11658-013-0088-x",
      "author": "A Korlimarla",
      "doi-asserted-by": "publisher",
      "first-page": "284",
      "issue": "2",
      "journal-title": "Cell Mol Biol Lett",
      "key": "183_CR7",
      "unstructured": "Korlimarla A, Bhandary L, Prabhu JS, Shankar H, Sankaranarayanan H, Kumar P, et al. Identification of a non-canonical nuclear localization signal (NLS) in BRCA1 that could mediate nuclear localization of splice variants lacking the classical NLS. Cell Mol Biol Lett. 2013;18(2):284–96.",
      "volume": "18",
      "year": "2013"
    },
    {
      "DOI": "10.1074/jbc.271.51.32863",
      "author": "CF Chen",
      "doi-asserted-by": "publisher",
      "first-page": "32863",
      "issue": "51",
      "journal-title": "J Biol Chem",
      "key": "183_CR8",
      "unstructured": "Chen CF, Li S, Chen Y, Chen PL, Sharp ZD, Lee WH. The nuclear localization sequences of the BRCA1 protein interact with the importin-alpha subunit of the nuclear transport signal receptor. J Biol Chem. 1996;271(51):32863–8.",
      "volume": "271",
      "year": "1996"
    },
    {
      "DOI": "10.1128/MCB.17.1.444",
      "author": "S Thakur",
      "doi-asserted-by": "publisher",
      "first-page": "444",
      "issue": "1",
      "journal-title": "Mol Cell Biol",
      "key": "183_CR9",
      "unstructured": "Thakur S, Zhang HB, Peng Y, Le H, Carroll B, Ward T, et al. Localization of BRCA1 and a splice variant identifies the nuclear localization signal. Mol Cell Biol. 1997;17(1):444–52.",
      "volume": "17",
      "year": "1997"
    },
    {
      "DOI": "10.5936/csbj.201204005",
      "author": "Serena L. Clark",
      "doi-asserted-by": "publisher",
      "first-page": "e201204005",
      "issue": "1",
      "journal-title": "Computational and Structural Biotechnology Journal",
      "key": "183_CR10",
      "unstructured": "Clark SL, Rodriguez AM, Snyder RR, Hankins GD, Boehning D. Structure-function of the tumor suppressor BRCA1. Comput Struct Biotechnol J. 2012;1(1). \n                    https://doi.org/10.5936/csbj.201204005\n                    \n                  .",
      "volume": "1",
      "year": "2012"
    },
    {
      "DOI": "10.1126/science.7545954",
      "author": "Y Miki",
      "doi-asserted-by": "publisher",
      "first-page": "66",
      "issue": "5182",
      "journal-title": "Science",
      "key": "183_CR11",
      "unstructured": "Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994;266(5182):66–71.",
      "volume": "266",
      "year": "1994"
    },
    {
      "DOI": "10.1073/pnas.93.24.13595",
      "author": "AN Monteiro",
      "doi-asserted-by": "publisher",
      "first-page": "13595",
      "issue": "24",
      "journal-title": "Proc Natl Acad Sci U S A",
      "key": "183_CR12",
      "unstructured": "Monteiro AN, August A, Hanafusa H. Evidence for a transcriptional activation function of BRCA1 C-terminal region. Proc Natl Acad Sci U S A. 1996;93(24):13595–9.",
      "volume": "93",
      "year": "1996"
    },
    {
      "DOI": "10.1101/cshperspect.a016600",
      "author": "R Prakash",
      "doi-asserted-by": "publisher",
      "first-page": "a016600",
      "issue": "4",
      "journal-title": "Cold Spring Harb Perspect Biol",
      "key": "183_CR13",
      "unstructured": "Prakash R, Zhang Y, Feng W, Jasin M. Homologous recombination and human health: the roles of BRCA1, BRCA2, and associated proteins. Cold Spring Harb Perspect Biol. 2015;7(4):a016600.",
      "volume": "7",
      "year": "2015"
    },
    {
      "DOI": "10.1126/science.1209909",
      "author": "R Shakya",
      "doi-asserted-by": "publisher",
      "first-page": "525",
      "issue": "6055",
      "journal-title": "Science",
      "key": "183_CR14",
      "unstructured": "Shakya R, Reid LJ, Reczek CR, Cole F, Egli D, Lin CS, et al. BRCA1 tumor suppression depends on BRCT phosphoprotein binding, but not its E3 ligase activity. Science. 2011;334(6055):525–8.",
      "volume": "334",
      "year": "2011"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-04-3995",
      "author": "AL Gartel",
      "doi-asserted-by": "publisher",
      "first-page": "3980",
      "issue": "10",
      "journal-title": "Cancer Res",
      "key": "183_CR15",
      "unstructured": "Gartel AL, Radhakrishnan SK. Lost in transcription: p21 repression, mechanisms, and consequences. Cancer Res. 2005;65(10):3980–5.",
      "volume": "65",
      "year": "2005"
    },
    {
      "DOI": "10.1038/38291",
      "author": "K Somasundaram",
      "doi-asserted-by": "publisher",
      "first-page": "187",
      "issue": "6647",
      "journal-title": "Nature",
      "key": "183_CR16",
      "unstructured": "Somasundaram K, Zhang H, Zeng YX, Houvras Y, Peng Y, Zhang H, et al. Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiP1. Nature. 1997;389(6647):187–90.",
      "volume": "389",
      "year": "1997"
    },
    {
      "DOI": "10.1074/jbc.275.4.2777",
      "author": "TK MacLachlan",
      "doi-asserted-by": "publisher",
      "first-page": "2777",
      "issue": "4",
      "journal-title": "J Biol Chem",
      "key": "183_CR17",
      "unstructured": "MacLachlan TK, Somasundaram K, Sgagias M, Shifman Y, Muschel RJ, Cowan KH, et al. BRCA1 effects on the cell cycle and the DNA damage response are linked to altered gene expression. J Biol Chem. 2000;275(4):2777–85.",
      "volume": "275",
      "year": "2000"
    },
    {
      "DOI": "10.1038/ng837",
      "author": "RI Yarden",
      "doi-asserted-by": "publisher",
      "first-page": "285",
      "issue": "3",
      "journal-title": "Nat Genet",
      "key": "183_CR18",
      "unstructured": "Yarden RI, Pardo-Reoyo S, Sgagias M, Cowan KH, Brody LC. BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage. Nat Genet. 2002;30(3):285–9.",
      "volume": "30",
      "year": "2002"
    },
    {
      "DOI": "10.1038/sj.onc.1209872",
      "author": "PB Mullan",
      "doi-asserted-by": "publisher",
      "first-page": "5854",
      "issue": "43",
      "journal-title": "Oncogene",
      "key": "183_CR19",
      "unstructured": "Mullan PB, Quinn JE, Harkin DP. The role of BRCA1 in transcriptional regulation and cell cycle control. Oncogene. 2006;25(43):5854–63.",
      "volume": "25",
      "year": "2006"
    },
    {
      "DOI": "10.1073/pnas.96.7.3706",
      "author": "XW Wang",
      "doi-asserted-by": "publisher",
      "first-page": "3706",
      "issue": "7",
      "journal-title": "Proc Natl Acad Sci U S A",
      "key": "183_CR20",
      "unstructured": "Wang XW, Zhan Q, Coursen JD, Khan MA, Kontny HU, Yu L, et al. GADD45 induction of a G2/M cell cycle checkpoint. Proc Natl Acad Sci U S A. 1999;96(7):3706–11.",
      "volume": "96",
      "year": "1999"
    },
    {
      "DOI": "10.1038/sj.onc.1204073",
      "author": "S Fan",
      "doi-asserted-by": "publisher",
      "first-page": "77",
      "issue": "1",
      "journal-title": "Oncogene",
      "key": "183_CR21",
      "unstructured": "Fan S, Ma YX, Wang C, Yuan RQ, Meng Q, Wang JA, et al. Role of direct interaction in BRCA1 inhibition of estrogen receptor activity. Oncogene. 2001;20(1):77–87.",
      "volume": "20",
      "year": "2001"
    },
    {
      "DOI": "10.7150/ijbs.8579",
      "author": "L Wang",
      "doi-asserted-by": "publisher",
      "first-page": "566",
      "issue": "5",
      "journal-title": "Int J Biol Sci",
      "key": "183_CR22",
      "unstructured": "Wang L, Di LJ. BRCA1 and estrogen/estrogen receptor in breast cancer: where they interact? Int J Biol Sci. 2014;10(5):566–75.",
      "volume": "10",
      "year": "2014"
    },
    {
      "DOI": "10.1007/s10549-010-1169-4",
      "author": "BM Simoes",
      "doi-asserted-by": "publisher",
      "first-page": "23",
      "issue": "1",
      "journal-title": "Breast Cancer Res Treat",
      "key": "183_CR23",
      "unstructured": "Simoes BM, Piva M, Iriondo O, Comaills V, Lopez-Ruiz JA, Zabalza I, et al. Effects of estrogen on the proportion of stem cells in the breast. Breast Cancer Res Treat. 2011;129(1):23–35.",
      "volume": "129",
      "year": "2011"
    },
    {
      "DOI": "10.1128/MCB.24.16.6947-6956.2004",
      "author": "A Moisan",
      "doi-asserted-by": "publisher",
      "first-page": "6947",
      "issue": "16",
      "journal-title": "Mol Cell Biol",
      "key": "183_CR24",
      "unstructured": "Moisan A, Larochelle C, Guillemette B, Gaudreau L. BRCA1 can modulate RNA polymerase II carboxy-terminal domain phosphorylation levels. Mol Cell Biol. 2004;24(16):6947–56.",
      "volume": "24",
      "year": "2004"
    },
    {
      "DOI": "10.1038/gim.2015.180",
      "author": "W Song",
      "doi-asserted-by": "publisher",
      "first-page": "850",
      "issue": "8",
      "journal-title": "Genet Med",
      "key": "183_CR25",
      "unstructured": "Song W, Gardner SA, Hovhannisyan H, Natalizio A, Weymouth KS, Chen W, et al. Exploring the landscape of pathogenic genetic variation in the ExAC population database: insights of relevance to variant classification. Genet Med. 2016;18(8):850–4.",
      "volume": "18",
      "year": "2016"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-06-3297",
      "author": "MA Carvalho",
      "doi-asserted-by": "publisher",
      "first-page": "1494",
      "issue": "4",
      "journal-title": "Cancer Res",
      "key": "183_CR26",
      "unstructured": "Carvalho MA, Marsillac SM, Karchin R, Manoukian S, Grist S, Swaby RF, et al. Determination of cancer risk associated with germ line BRCA1 missense variants by functional analysis. Cancer Res. 2007;67(4):1494–501.",
      "volume": "67",
      "year": "2007"
    },
    {
      "DOI": "10.1007/s10689-016-9916-2",
      "author": "Elisabeth Jarhelle",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "issue": "1",
      "journal-title": "Familial Cancer",
      "key": "183_CR27",
      "unstructured": "Jarhelle E, Riise Stensland HMF, Mæhle L, et al. Familial Cancer. 2017;16:1. \n                    https://doi.org/10.1007/s10689-016-9916-2\n                    \n                  .",
      "volume": "16",
      "year": "2016"
    },
    {
      "DOI": "10.1038/ncomms10086",
      "author": "C Lu",
      "doi-asserted-by": "publisher",
      "first-page": "10086",
      "journal-title": "Nat Commun",
      "key": "183_CR28",
      "unstructured": "Lu C, Xie M, Wendl MC, Wang J, McLellan MD, Leiserson MD, et al. Patterns and functional implications of rare germline variants across 12 cancer types. Nat Commun. 2015;6:10086.",
      "volume": "6",
      "year": "2015"
    },
    {
      "DOI": "10.1158/1055-9965.EPI-10-1214",
      "author": "ES Iversen Jr",
      "doi-asserted-by": "publisher",
      "first-page": "1078",
      "issue": "6",
      "journal-title": "Cancer Epidemiol Biomark Prev",
      "key": "183_CR29",
      "unstructured": "Iversen ES Jr, Couch FJ, Goldgar DE, Tavtigian SV, Monteiro AN. A computational method to classify variants of uncertain significance using functional assay data with application to BRCA1. Cancer Epidemiol Biomark Prev. 2011;20(6):1078–88.",
      "volume": "20",
      "year": "2011"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-09-4563",
      "author": "MS Lee",
      "doi-asserted-by": "publisher",
      "first-page": "4880",
      "issue": "12",
      "journal-title": "Cancer Res",
      "key": "183_CR30",
      "unstructured": "Lee MS, Green R, Marsillac SM, Coquelle N, Williams RS, Yeung T, et al. Comprehensive analysis of missense variations in the BRCT domain of BRCA1 by structural and functional assays. Cancer Res. 2010;70(12):4880–90.",
      "volume": "70",
      "year": "2010"
    },
    {
      "DOI": "10.1093/hmg/10.4.353",
      "author": "J Vallon-Christersson",
      "doi-asserted-by": "publisher",
      "first-page": "353",
      "issue": "4",
      "journal-title": "Hum Mol Genet",
      "key": "183_CR31",
      "unstructured": "Vallon-Christersson J, Cayanan C, Haraldsson K, Loman N, Bergthorsson JT, Brondum-Nielsen K, et al. Functional analysis of BRCA1 C-terminal missense mutations identified in breast and ovarian cancer families. Hum Mol Genet. 2001;10(4):353–60.",
      "volume": "10",
      "year": "2001"
    },
    {
      "DOI": "10.1158/2159-8290.CD-13-0094",
      "author": "P Bouwman",
      "doi-asserted-by": "publisher",
      "first-page": "1142",
      "issue": "10",
      "journal-title": "Cancer Discov",
      "key": "183_CR32",
      "unstructured": "Bouwman P, van der Gulden H, van der Heijden I, Drost R, Klijn CN, Prasetyanti P, et al. A high-throughput functional complementation assay for classification of BRCA1 missense variants. Cancer Discov. 2013;3(10):1142–55.",
      "volume": "3",
      "year": "2013"
    },
    {
      "DOI": "10.1136/jmedgenet-2012-101037",
      "author": "AB Spurdle",
      "doi-asserted-by": "publisher",
      "first-page": "525",
      "issue": "8",
      "journal-title": "J Med Genet",
      "key": "183_CR33",
      "unstructured": "Spurdle AB, Whiley PJ, Thompson B, Feng B, Healey S, Brown MA, et al. BRCA1 R1699Q variant displaying ambiguous functional abrogation confers intermediate breast and ovarian cancer risk. J Med Genet. 2012;49(8):525–32.",
      "volume": "49",
      "year": "2012"
    },
    {
      "DOI": "10.1136/jmedgenet-2017-104560",
      "author": "S Moghadasi",
      "doi-asserted-by": "publisher",
      "first-page": "15",
      "issue": "1",
      "journal-title": "J Med Genet",
      "key": "183_CR34",
      "unstructured": "Moghadasi S, Meeks HD, Vreeswijk MP, Janssen LA, Borg A, Ehrencrona H, et al. The BRCA1 c. 5096G\u003eA p.Arg1699Gln (R1699Q) intermediate risk variant: breast and ovarian cancer risk estimation and recommendations for clinical management from the ENIGMA consortium. J Med Genet. 2018;55(1):15–20.",
      "volume": "55",
      "year": "2018"
    },
    {
      "DOI": "10.1186/bcr1826",
      "author": "PK Lovelock",
      "doi-asserted-by": "publisher",
      "first-page": "R82",
      "issue": "6",
      "journal-title": "Breast Cancer Res",
      "key": "183_CR35",
      "unstructured": "Lovelock PK, Spurdle AB, Mok MT, Farrugia DJ, Lakhani SR, Healey S, et al. Identification of BRCA1 missense substitutions that confer partial functional activity: potential moderate risk variants? Breast Cancer Res. 2007;9(6):R82.",
      "volume": "9",
      "year": "2007"
    },
    {
      "DOI": "10.4161/cbt.3.5.809",
      "author": "RS Coyne",
      "doi-asserted-by": "publisher",
      "first-page": "453",
      "issue": "5",
      "journal-title": "Cancer Biol Ther",
      "key": "183_CR36",
      "unstructured": "Coyne RS, McDonald HB, Edgemon K, Brody LC. Functional characterization of BRCA1 sequence variants using a yeast small colony phenotype assay. Cancer Biol Ther. 2004;3(5):453–7.",
      "volume": "3",
      "year": "2004"
    },
    {
      "DOI": "10.1042/BJ20141077",
      "author": "DC Gaboriau",
      "doi-asserted-by": "publisher",
      "first-page": "613",
      "issue": "3",
      "journal-title": "Biochem J",
      "key": "183_CR37",
      "unstructured": "Gaboriau DC, Rowling PJ, Morrison CG, Itzhaki LS. Protein stability versus function: effects of destabilizing missense mutations on BRCA1 DNA repair activity. Biochem J. 2015;466(3):613–24.",
      "volume": "466",
      "year": "2015"
    },
    {
      "DOI": "10.1002/prot.22460",
      "author": "I Drikos",
      "doi-asserted-by": "publisher",
      "first-page": "464",
      "issue": "2",
      "journal-title": "Proteins",
      "key": "183_CR38",
      "unstructured": "Drikos I, Nounesis G, Vorgias CE. Characterization of cancer-linked BRCA1-BRCT missense variants and their interaction with phosphoprotein targets. Proteins. 2009;77(2):464–76.",
      "volume": "77",
      "year": "2009"
    },
    {
      "DOI": "10.1007/s00439-004-1240-5",
      "author": "R McKean-Cowdin",
      "doi-asserted-by": "publisher",
      "first-page": "497",
      "issue": "6",
      "journal-title": "Hum Genet",
      "key": "183_CR39",
      "unstructured": "McKean-Cowdin R, Spencer Feigelson H, Xia LY, Pearce CL, Thomas DC, Stram DO, et al. BRCA1 variants in a family study of African-American and Latina women. Hum Genet. 2005;116(6):497–506.",
      "volume": "116",
      "year": "2005"
    },
    {
      "DOI": "10.1038/s41586-018-0461-z",
      "author": "GM Findlay",
      "doi-asserted-by": "publisher",
      "first-page": "217",
      "issue": "7726",
      "journal-title": "Nature",
      "key": "183_CR40",
      "unstructured": "Findlay GM, Daza RM, Martin B, Zhang MD, Leith AP, Gasperini M, et al. Accurate classification of BRCA1 variants with saturation genome editing. Nature. 2018;562(7726):217–22.",
      "volume": "562",
      "year": "2018"
    },
    {
      "DOI": "10.1016/j.ajhg.2018.07.016",
      "author": "LM Starita",
      "doi-asserted-by": "publisher",
      "first-page": "498",
      "issue": "4",
      "journal-title": "Am J Hum Genet",
      "key": "183_CR41",
      "unstructured": "Starita LM, Islam MM, Banerjee T, Adamovich AI, Gullingsrud J, Fields S, et al. A multiplex homology-directed DNA repair assay reveals the impact of more than 1,000 BRCA1 missense substitution variants on protein function. Am J Hum Genet. 2018;103(4):498–508.",
      "volume": "103",
      "year": "2018"
    },
    {
      "DOI": "10.1534/genetics.115.175802",
      "author": "LM Starita",
      "doi-asserted-by": "publisher",
      "first-page": "413",
      "issue": "2",
      "journal-title": "Genetics",
      "key": "183_CR42",
      "unstructured": "Starita LM, Young DL, Islam M, Kitzman JO, Gullingsrud J, Hause RJ, et al. Massively parallel functional analysis of BRCA1 RING domain variants. Genetics. 2015;200(2):413–22.",
      "volume": "200",
      "year": "2015"
    },
    {
      "DOI": "10.1089/gte.2006.10.200",
      "author": "B Kaufman",
      "doi-asserted-by": "publisher",
      "first-page": "200",
      "issue": "3",
      "journal-title": "Genet Test",
      "key": "183_CR43",
      "unstructured": "Kaufman B, Laitman Y, Carvalho MA, Edelman L, Menachem TD, Zidan J, et al. The P1812A and P25T BRCA1 and the 5164del4 BRCA2 mutations: occurrence in high-risk non-Ashkenazi Jews. Genet Test. 2006;10(3):200–7.",
      "volume": "10",
      "year": "2006"
    },
    {
      "DOI": "10.1136/jmg.2004.024711",
      "author": "CM Phelan",
      "doi-asserted-by": "publisher",
      "first-page": "138",
      "issue": "2",
      "journal-title": "J Med Genet",
      "key": "183_CR44",
      "unstructured": "Phelan CM, Dapic V, Tice B, Favis R, Kwan E, Barany F, et al. Classification of BRCA1 missense variants of unknown clinical significance. J Med Genet. 2005;42(2):138–46.",
      "volume": "42",
      "year": "2005"
    },
    {
      "DOI": "10.1038/ejhg.2008.13",
      "author": "M Tischkowitz",
      "doi-asserted-by": "publisher",
      "first-page": "820",
      "issue": "7",
      "journal-title": "Eur J Hum Genet",
      "key": "183_CR45",
      "unstructured": "Tischkowitz M, Hamel N, Carvalho MA, Birrane G, Soni A, van Beers EH, et al. Pathogenicity of the BRCA1 missense variant M1775K is determined by the disruption of the BRCT phosphopeptide-binding pocket: a multi-modal approach. Eur J Hum Genet. 2008;16(7):820–32.",
      "volume": "16",
      "year": "2008"
    },
    {
      "DOI": "10.1016/j.biocel.2006.08.002",
      "author": "MA Carvalho",
      "doi-asserted-by": "publisher",
      "first-page": "298",
      "issue": "2",
      "journal-title": "Int J Biochem Cell Biol",
      "key": "183_CR46",
      "unstructured": "Carvalho MA, Couch FJ, Monteiro AN. Functional assays for BRCA1 and BRCA2. Int J Biochem Cell Biol. 2007;39(2):298–310.",
      "volume": "39",
      "year": "2007"
    }
  ],
  "reference-count": 46,
  "references-count": 46,
  "resource": {
    "primary": {
      "URL": "https://humgenomics.biomedcentral.com/articles/10.1186/s40246-018-0183-1"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genomics"
  ],
  "source": "Crossref",
  "title": [
    "Trans-activation-based risk assessment of BRCA1 BRCT variants with unknown clinical significance"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "12"
}